Arcutis Biotherapeutics, Inc.
ARQT
$26.23
$0.311.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.01% | 13.08% | -3.06% | -42.20% | -47.35% |
| Total Receivables | 45.44% | 69.03% | 100.13% | 91.48% | 145.76% |
| Inventory | 138.17% | 125.06% | 55.82% | 59.96% | 17.61% |
| Prepaid Expenses | 107.40% | 1.74% | -5.64% | 16.66% | -25.93% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 66.39% | 112.13% | 22.63% | 0.19% | 226.01% |
| Total Current Assets | 40.54% | 35.34% | 22.46% | -17.58% | -23.43% |
|
|
|||||
| Total Current Assets | 40.54% | 35.34% | 22.46% | -17.58% | -23.43% |
| Net Property, Plant & Equipment | 64.16% | 61.80% | 84.03% | 78.13% | -11.05% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -14.12% | -13.64% | 56.26% | 57.02% | 162.86% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 244.63% | 285.23% | 138.09% | 0.00% | 0.17% |
| Total Assets | 38.62% | 33.68% | 24.10% | -15.18% | -20.76% |
|
|
|||||
| Total Accounts Payable | -56.21% | -25.41% | -11.90% | -70.01% | 89.88% |
| Total Accrued Expenses | 67.08% | 108.27% | 73.69% | 76.12% | 106.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 595.00% | 844.18% | -- | -99.00% | 28.70% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 54.27% | 79.09% | 60.27% | -42.14% | 102.40% |
|
|
|||||
| Total Current Liabilities | 54.27% | 79.09% | 60.27% | -42.14% | 102.40% |
| Long-Term Debt | -4.76% | -5.71% | 0.71% | 2.29% | -47.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 147.73% | 124.40% | 105.54% | 90.33% | -29.01% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.72% | 19.72% | -24.39% | -14.29% | 85.57% |
| Total Liabilities | 25.53% | 34.21% | 27.25% | -24.16% | -17.37% |
|
|
|||||
| Common Stock & APIC | 4.13% | 3.86% | 3.76% | 3.66% | 3.63% |
| Retained Earnings | 2.45% | -0.21% | -1.44% | -3.99% | -8.72% |
| Treasury Stock & Other | -1,774.29% | -267.14% | -528.57% | -111.63% | 88.10% |
| Total Common Equity | 58.72% | 32.94% | 20.27% | 0.91% | -25.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 58.72% | 32.94% | 20.27% | 0.91% | -25.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 58.72% | 32.94% | 20.27% | 0.91% | -25.45% |
|
|
|||||